For more than eight years, NovaSom has provided physicians and their patients with home-sleep testing services that deliver improved accuracy and reduced testing variability than conventional polysolmnography (PSG).

As an innovator and pioneer in our field, we developed the first FDA-cleared device designed for unattended, unassisted patient use with clinically proven equivalence to conventional PSG for the diagnosis of sleep apnea.

Our leading-edge technology and simplified engineering make the test easy for patients to administer, a factor that has been shown to improve participation rates. The test is taken over multiple nights, which has been shown to identify more at-risk patients than single night tests, whether administered at home or in a sleep lab.

Our skilled staff works closely with physicians to ensure that patients receive prescribed diagnostic tests in a timely manner, typically within a week. Once the test is prescribed, NovaSom assumes responsibility of the testing process.